Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Acral Melanoma”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Testing effectiveness (Phase 2)Ended earlyNCT01120275
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Who this might be right for
Acral Lentiginous Malignant MelanomaLentigo Maligna Malignant MelanomaNodular Malignant Melanoma+4 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Looking for participantsNCT06961357
What this trial is testing

Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 36
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07347444
What this trial is testing

Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma

Who this might be right for
Acral MelanomaMucosal Melanoma
Fudan University 48
Early research (Phase 1)Looking for participantsNCT05098210
What this trial is testing

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more
Fred Hutchinson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT01395121
What this trial is testing

A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread

Who this might be right for
Mucosal Lentiginous MelanomaAcral Lentiginous Malignant Melanoma
Institute of Cancer Research, United Kingdom 29
Testing effectiveness (Phase 2)UnknownNCT04397770
What this trial is testing

Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 40
Testing effectiveness (Phase 2)Study completedNCT02875132
What this trial is testing

Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma

Who this might be right for
Acral Lentiginous Melanoma
Chinese University of Hong Kong 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04462406
What this trial is testing

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

Who this might be right for
Advanced MelanomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+8 more
ECOG-ACRIN Cancer Research Group 150
Testing effectiveness (Phase 2)UnknownNCT03991975
What this trial is testing

Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Acral Malignant Melanoma

Who this might be right for
Advanced Acral Malignant Melanoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 42
Testing effectiveness (Phase 2)UnknownNCT03955354
What this trial is testing

PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 30
Testing effectiveness (Phase 2)Ended earlyNCT02978443
What this trial is testing

A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab

Who this might be right for
Acral Lentiginous MelanomaMucosal Melanoma
Georgetown University 14
Early research (Phase 1)Ended earlyNCT02346955
What this trial is testing

Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)

Who this might be right for
Non-small Cell Lung Carcinoma (NSCLC)MelanomaBladder Cancer+3 more
Famewave Ltd. 27
Large-scale testing (Phase 3)Looking for participantsNCT05549297
What this trial is testing

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Who this might be right for
Advanced Melanoma
Immunocore Ltd 540
Testing effectiveness (Phase 2)Looking for participantsNCT06797297
What this trial is testing

Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy

Who this might be right for
Melanoma
Innovent Biologics (Suzhou) Co. Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT02071940
What this trial is testing

PLX3397 KIT in Acral aNd mucOsal Melanoma

Who this might be right for
Malignant Melanoma
The Christie NHS Foundation Trust 7
Testing effectiveness (Phase 2)Study completedNCT00700882
What this trial is testing

Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 81
Early research (Phase 1)Looking for participantsNCT04485013
What this trial is testing

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

Who this might be right for
Cancer
Tizona Therapeutics, Inc 240
Testing effectiveness (Phase 2)Looking for participantsNCT07155317
What this trial is testing

Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial

Who this might be right for
Advanced Acral MelanomaAdvanced Cutaneous MelanomaAdvanced Mucosal Melanoma+7 more
Emory University 99
Testing effectiveness (Phase 2)UnknownNCT05087602
What this trial is testing

Toripalimab Combined With Anlotinib in Unresectable Locally Advanced or Metastatic Acral Malignant Melanoma

Who this might be right for
Locally Advanced or Metastatic Acral Malignant Melanoma
Qilu Hospital of Shandong University 29
Load More Results